SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
June 14, 2013
APOLLO MEDICAL HOLDINGS, INC.
(Exact name of registrant as specified in
|(State or Other Jurisdiction
700 N. Brand Blvd., Suite 220, Glendale,
(Address of principal executive offices)
(Registrant's telephone number, including
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On June 14, 2013, Apollo Medical Holdings, Inc. issued a press
release announcing its results of operations for the three months ended April 30, 2013. The press release is furnished herewith
as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
|99.1||Press Release of Apollo Medical Holdings, Inc. dated
June 14, 2013
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
||APOLLO MEDICAL HOLDINGS, INC.|
|Dated: June 18, 2013
||/s/ Warren Hosseinion|
||Chief Executive Officer|